In vitro fertilization nearly doubles in 5 years
Embryos produced via in vitro fertilization have surged by 83.2 percent in South Korea over the past five years, according to government data released Thursday, signaling the growing use of assisted reproductive technology in a country grappling with low birth rates.
A total of 783,860 embryos were created through IVF in 2024, up from 427,818 in 2019, according to the Ministry of Health and Welfare data submitted to Rep. Kim Yoon of the ruling Democratic Party of Korea. The number has been steadily climbing since 2016, when 334,687 embryos were created, and surpassed 500,000 for the first time in 2021.
The actual embryo transfer has also increased in recent years, although not as rapidly. Last year, 201,496 embryos were transferred for pregnancy, up 31.9 percent from 152,761 in 2019 and 56.6 percent from 128,672 in 2016.
IVF is a procedure to aid pregnancy, where mature eggs are collected and fertilized by sperm in a laboratory setting. The fertilized eggs are transferred to a human body for pregnancy or cryopreserved for future use.
As of December 2024, medical institutions across the country were storing 383,520 embryos, along with 133,926 unfertilized eggs and 56,967 vials of semen.
However, most fertilized embryos end up being discarded. In 2024 alone, 533,266 embryos were destroyed, more than double the 260,506 discarded in 2019. Embryos may be discarded for various reasons, including being deemed unfit for pregnancy or upon request by the individuals who created them.
Frozen embryos can theoretically be stored indefinitely if maintained properly, but most people only store them for up to 10 years.
In vitro fertilization becoming more crucial, but controversy remains
IVF is becoming an increasingly vital option in South Korea, where the average age of first-time mothers was 32.96 as of 2023. Advanced maternal age is medically defined as 35 or older, which means a substantial number of Korean couples are presumed to have some complications when trying to conceive naturally.
Despite the many advantages of assisted pregnancy technology, some ethical questions are not yet covered by the Bioethics and Safety Act.
Earlier in July, actor Lee Si-young revealed that she had gotten pregnant via embryo created with her ex-husband, despite his opposition. This is due to a loophole in the law: It mandates a written consent when creating embryos via in vitro fertilization, but has no clause on transferring the already-created embryos to the human body.
The incident has touched off controversy about the bioethics of the embryo and in vitro fertilization, which is still a relatively new field in the world and particularly in South Korea. The Bioethics and Safety Act itself, which covers the matters related to embryos, was only enacted in 2004 and came into effect the following year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
a day ago
- Korea Herald
KGC unveils ginseng for each stage of life at Singapore health forum
Korea Ginseng Corp., a leading manufacturer of ginseng products, showcased emerging Korean health trends and the scientific evidence for the effectiveness of its flagship brand JungKwanJang, at an Asia's premier health food industry forum in Singapore. KGC presented its advanced R&D capabilities and a broad lineup tailored to different life stages — from Korean Red Ginseng Extract Everytime to products designed for teens, students, women and seniors. The Growth Asia Summit 2025 was held from July 15-17 and brought together over 300 health experts from more than 15 countries, alongside industry leaders like Nestle and Danone. The firm also unveiled new product innovations, including RXGIN red ginseng oil for men's prostate health and GLPro, a clinically tested solution for improving blood sugar indicators. Officially recognized by Korea's Ministry of Food and Drug Safety, red ginseng is known for its seven key health benefits, including immunity support and fatigue relief. 'This summit was a valuable opportunity to highlight the strengths of K-ginseng,' said Kai Lee, head of the global market development team at KGC. "We are committed to advancing the global reach of K-ginseng." KGC has maintained its position as the No. 1 global ginseng brand for 11 consecutive years, according to UK-based market research firm Euromonitor.
Korea Herald
2 days ago
- Korea Herald
Size matters? Unpacking penile surgery trends in Korea
From 'sunflower' techniques to fat grafting, penile enlargement has evolved into one of the most sought-after male sexual surgeries in Korea — but risks remain Lim, a 30-year-old office worker, was taken aback when she first saw her new boyfriend's altered anatomy. He had undergone surgery to insert silicone implants in the shape of beads or rings beneath the skin of the glans, transforming the penis into a sunflower-like shape, commonly known as Sunflower Surgery or T-Ring Surgery here. "I was surprised, but it was a good surprise — a positive one," she remarked. This surgery is primarily used to increase girth and enhance sexual pleasure by allowing the implants to rub against the vaginal walls during intercourse, delivering intense orgasmic sensations, according to Lim. Historically, bigger has not always meant better. Some cultures preferred a more compact member. According to research by historian Paul Chrystal, the ancient Greeks associated smaller penises with their ideals of male beauty, viewing them as symbols of sophisticated culture and civilization. This perspective is highlighted in Chrystal's book "In Bed with the Ancient Greeks." Despite these historical exceptions, penile enlargement continues to be one of the most common sexual surgeries pursued by men in Korea today. For many, size does indeed matter. Men are often subjected to societal pressures — both explicit and implicit — that suggest small is shameful, frequently making penis size a subject of humor and jokes. Perhaps due to this backdrop, Korean men show keen interest in penile enlargement surgeries, and many, like 35-year-old office worker surnamed Ha, report undergoing such procedures. 'I had penile enlargement surgery, and I am a former army non-commissioned officer. Most of my unit's peers, juniors and seniors also had it done.' Ha underwent the sunflower surgery about 10 years ago. Prices for the basic procedure start at around 500,000 won ($365), with additional features costing more. Ha, who declined to offer his full name, expressed satisfaction with the procedure, stating, "My girlfriends are satisfied, and my former colleagues say their wives and girlfriends are satisfied too." However, he noted occasional discomfort, feeling as if foreign objects were lodged inside. Another individual, a 25-year-old university student using the pseudonym Kim Min-jae, underwent penile enlargement surgery at a urology clinic in Gangnam, Seoul, last year. Kim explained that his motivation for the surgery stemmed from a painful personal experience. "I happened to see an Instagram DM exchange a few years ago, between my then-girlfriend and her friend discussing their sexual experiences with their partners," he said. "She mentioned that mine was significantly smaller than her previous boyfriends' and that she couldn't feel much pleasure with me. Discovering this by chance on her phone was devastating and led me to a point of depression." Determined to address his perceived inadequacy, Kim measured his penis and found that while his length was within the average range, his girth was about 1 cm less than average. This realization prompted him to consider surgery. He opted for a "fat grafting" procedure, also known as fat transfer phalloplasty, which involves extracting fat from areas like the inner thigh or abdomen, purifying it, transferring it into syringes and evenly injecting it into the penile shaft to increase girth. "Immediately after the surgery, my girth increased by 1.5 to 2 centimeters, and after six months, it stabilized at about 1 centimeter more. Although the pain when waking from anesthesia was intense, I've since felt much less self-conscious," Kim said. Dr. Lee Haeng-nam, a specialist in urology, stated, "Using one's own fat eliminates the risk of allergic reactions, leading to a lower likelihood of complications. Due to these advantages, four out of five patients seeking penis enlargement surgery, regardless of age, choose this procedure and report high satisfaction." The benefits of this procedure are supported by a study published in Aesthetic Plastic Surgery in September 2011, which reported an overall patient satisfaction rate of 92 percent and a satisfaction rate regarding the shape of 90 percent. The study found an average increase in penile girth of 2.3 cm post-surgery, according to Lee. Lee also noted that while this procedure is beneficial for the general population, individuals with naturally small penises or micropenis conditions may find particularly high satisfaction levels. According to Lee, the average penile girth for Korean men is between 6 to 7cm when flaccid, but 25 percent of Korean men either have a "micropenis" — less than 4 cm — or experience dissatisfaction, known as micropenis complex. These procedures, however, come with reports of ineffectiveness or severe side effects. The American Urological Association warns that most penile enlargement techniques are ineffective and risky, citing complications such as ineffective fat injections, unsafe ligament divisions and various surgical risks. An anonymous individual recently shared his experience on the online forum DC Gallery about undergoing augmentation with dermal substitutes in Korea. He described enduring severe pain, incurring costs of 4 million won to 5 million won, and experiencing inflammation, which ultimately required the removal of the dermal substitutes. "Before the surgery, my flaccid length was 5cm, and when erect, it was 11cm with a 10cm girth. After the surgery, there was only a slight increase in flaccid length, but I encountered relentless pain. Remember that satisfaction varies greatly between individuals; think twice before deciding.' jenn@
Korea Herald
3 days ago
- Korea Herald
Miracell launches Korea's first generative AI voice system for hospitals
Korean stem cell research company Miracell has introduced the nation's first generative AI-powered voice consultation system designed for medical institutions. Co-developed with Europe-based Vee, a Warsaw-listed AI company, the solution marks a major shift in healthcare automation. The company said Monday it has secured exclusive distribution rights for Vee's AI solution across Asia and is working closely with Vee Korea to customize the system for local hospitals. Unlike traditional rule-based ARS systems, the new AI tool uses natural language processing to deliver 24-hour conversational support, handling appointment scheduling, billing inquiries, patient reminders and general questions. The system is particularly effective during nights and weekends, when staffing is limited. It integrates with hospital customer relationship management systems and supports both inbound and outbound calls. Hospitals can trial the solution free for one month, lowering the adoption barrier. 'Generative AI can dramatically improve service quality in medical care,' said Shin Hyun-soon, CEO of Miracell. 'This isn't just an upgrade — it's a survival strategy for the health care sector.' Vee provides the underlying large language model engine, customized for Korean language and clinical context. A future version will link with Miracell's Celldoc platform, integrating patient consultations, appointments, and treatment records into a single interface. By combining its stem cell expertise with cutting-edge AI, Miracell aims to set a new standard in the health care industry. 'We're starting with clinics already using Smart-MCell,' a Miracell spokesperson said. 'But this is just the beginning. With AI, we hope to bring patients and caregivers even closer, and open the door to a more responsive, intelligent health care experience.'
